Ropes Wealth Advisors’s Precigen PGEN Stock Holding History

Ropes Wealth Advisors’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-200	Closed	-$2K	–	629
2020 Q4	$2K	Hold	200	–	–	﹤0.01%	655
2020 Q3	$1K	Hold	200	–	–	﹤0.01%	594
2020 Q2	$1K	Hold	200	–	–	﹤0.01%	558
2020 Q1	$1K	Hold	200	–	–	﹤0.01%	525
2019 Q4	$1K	Hold	200	–	–	﹤0.01%	525
2019 Q3	$1K	Hold	200	–	–	﹤0.01%	539
2019 Q2	$2K	Sell	200 -900	-82%	-$4.84K	﹤0.01%	544
2019 Q1	$6K	Buy	1,100 +200	+22%	+$1.39K	﹤0.01%	476
2018 Q4	$6K	Hold	900	–	–	﹤0.01%	450
2018 Q3	$15K	Hold	900	–	–	﹤0.01%	429
2018 Q2	$13K	Hold	900	–	–	﹤0.01%	455
2018 Q1	$14K	Hold	900	–	–	﹤0.01%	436
2017 Q4	$10K	Sell	900 -2,200	-71%	-$32.8K	﹤0.01%	534
2017 Q3	$59K	Hold	3,100	–	–	0.02%	314
2017 Q2	$75K	Buy	3,100 +700	+29%	+$15.3K	0.02%	288
2017 Q1	$48K	Buy	+2,400	New	+$53.6K	0.01%	335

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ropes Wealth Advisors's PGEN Position: Q1 2021 in Review

Ropes Wealth Advisors sold out of Precigen (PGEN) in Q1 2021, closing a stake of 200 shares — an estimated $2K sold.

Ropes Wealth Advisors first reported a position in PGEN in Q1 2017 and held it in 16 quarters. The position peaked at $75K in Q2 2017. 166 funds tracked by Wall St. Rank hold PGEN as of Q1 2021.

Ropes Wealth Advisors reported no remaining Precigen position as of Q1 2021 after selling out during the quarter.
Ropes Wealth Advisors sold 200 Precigen shares in Q1 2021, an estimated $2K.
Ropes Wealth Advisors first reported a position in Precigen in Q1 2017 and held it in 16 quarters.
Ropes Wealth Advisors's Precigen position peaked at $75K in Q2 2017.
166 funds tracked by Wall St. Rank held Precigen as of Q1 2021.

Based on Ropes Wealth Advisors's 13F filing for Q1 2021, filed 12 May 2021.